Davita Stock Price, News & Analysis (NYSE:DVA)

Davita trades on the New York Stock Exchange (NYSE) under the ticker symbol "DVA."

Davita Inc (NYSE:DVA) announced its quarterly earnings results on Thursday, August, 1st. The company reported $1.22 EPS for the quarter, topping the Zacks' consensus estimate of $1.10 by $0.12. The business had revenue of $2.84 billion for the quarter, compared to analysts' expectations of $2.86 billion. Davita had a return on equity of 14.67% and a net margin of 1.21%. The business's quarterly revenue was down 1.5% on a year-over-year basis. During the same period in the previous year, the firm earned $1.05 EPS. View Davita's Earnings History.

Davita is scheduled to release their next quarterly earnings announcement on Wednesday, November 6th 2019. View Earnings Estimates for Davita.

8 brokerages have issued 1 year price targets for Davita's stock. Their forecasts range from $60.00 to $70.00. On average, they expect Davita's stock price to reach $65.35 in the next twelve months. This suggests a possible upside of 11.4% from the stock's current price. View Analyst Price Targets for Davita.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Davita in the last year. There are currently 6 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Davita.

Press coverage about DVA stock has trended somewhat positive this week, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Davita earned a coverage optimism score of 0.8 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for Davita.

Davita saw a drop in short interest in the month of September. As of September 30th, there was short interest totalling 10,930,000 shares, a drop of 16.8% from the August 30th total of 13,130,000 shares. Based on an average daily volume of 3,100,000 shares, the days-to-cover ratio is currently 3.5 days. Approximately 7.1% of the shares of the company are short sold. View Davita's Current Options Chain.

Some companies that are related to Davita include Laboratory Corp. of America (LH), Quest Diagnostics (DGX), Chemed (CHE), Amedisys (AMED), LHC Group (LHCG), AMN Healthcare Services (AMN), MEDNAX (MD), CorVel (CRVL), R1 RCM (RCM), The Providence Service (PRSC), Tivity Health (TVTY), BioScrip (BIOS), Cross Country Healthcare (CCRN), Interpace Diagnostics Group (IDXG) and Bio-Reference Laboratories (BRLI).

Based on aggregate information from My MarketBeat watchlists, some companies that other Davita investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), AutoZone (AZO), Micron Technology (MU), Designer Brands (DBI), Precision Drilling (PD) and United Rentals (URI).

Davita's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Robeco Institutional Asset Management B.V. (0.05%), Brinker Capital Inc. (0.02%), Triad Investment Management (0.02%), Zurcher Kantonalbank Zurich Cantonalbank (0.02%), Crossmark Global Holdings Inc. (0.02%) and Nisa Investment Advisors LLC (0.02%). Company insiders that own Davita stock include Charles Berg, James K Hilger, Javier Rodriguez, Kent J Thiry, Leanne M Zumwalt, Pamela M Arway and William L Roper. View Institutional Ownership Trends for Davita.

DVA stock was sold by a variety of institutional investors in the last quarter, including Triad Investment Management, State of Alaska Department of Revenue, Lau Associates LLC, Stonebridge Capital Management Inc., CenturyLink Investment Management Co, Campbell & CO Investment Adviser LLC, Meeder Asset Management Inc. and Vigilant Capital Management LLC. View Insider Buying and Selling for Davita.

DVA stock was bought by a variety of institutional investors in the last quarter, including Robeco Institutional Asset Management B.V., Zurcher Kantonalbank Zurich Cantonalbank , Nisa Investment Advisors LLC, Rothschild Investment Corp IL, Robecosam AG, Whittier Trust Co., Brinker Capital Inc. and NuWave Investment Management LLC. View Insider Buying and Selling for Davita.

Shares of DVA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of DVA stock can currently be purchased for approximately $58.66.

Davita has a market capitalization of $9.40 billion and generates $11.40 billion in revenue each year. The company earns $159.39 million in net income (profit) each year or $3.57 on an earnings per share basis. Davita employs 77,700 workers across the globe.View Additional Information About Davita.

The official website for Davita is http://www.davita.com/.

Davita's mailing address is 2000 16TH STREET, DENVER CO, 80202. The company can be reached via phone at 720-631-2100 or via email at [email protected]